Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept effects on B cell bone marrow emigrants in RA
NCT01009879Phase 4Withdrawn
- Sponsor
- University of Pittsburgh
- Start
- Nov 2009
- Primary completion
- Feb 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by University of Pittsburgh. Planned start Nov 2009; status: withdrawn.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01009879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009879.